Impact on health outcomes of treating all eligible large B-cell lymphoma patients with axicabtagene ciloleucel in Portugal – A modeling approach

Authors:

Abstract
Cancer is the main cause of premature death in Portugal, and as such, reducing preventable and premature cancer deaths is one of the main public health priorities in the coming years1. In 2020, non...
Funding Information
  • Gilead Sciences

This publication has 33 references indexed in Scilit: